|
⚲
|
| Keyboard |
| Savitr Capital LLC
✚
|
|
|---|---|
| CRD # | 154510 |
| SEC # | 801-71908 |
| CIK # | 0001442757 |
| AUM | |
| Employees | |
| Fees | |
| Minimum | |
| Phone | 415-430-4200 |
| Address | One Market Plaza, Steuart Tower San Francisco, CA 94105 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| AP Pharma Inc /DE/ | 22.6 | ||
| USA Compression Partners LP | 2.4 | ||
| SPDR Gold Trust | 1.3 | ||
| Consol Energy Inc | 0.9 | ||
| Resources Connection Inc | 0.7 | ||
| Devon Energy Corp/DE | 0.6 | ||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Savitr Peak Energy Fund II LP | [2012-03-30] | 51.8 M | 69.8 M |
| Filed 2010-07-22 (D/A) · Exemption 506, 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Savitr Peak Energy Fund II Ltd | [2012-03-30] | 1.9 M | |
| Filed 2010-07-23 (D/A) · Exemption 506, 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Savitr Peak Energy Fund I Ltd | [2012-03-30] | 1.0 M | |
| Filed 2010-07-23 (D/A) · Exemption 506, 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Savitr Peak Energy Master Fund Ltd | 2012-03-30 | 67.5 M | |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 5 | 125.0 |
| By Discretionary | ||
| Discretionary | 5 | 125.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 5 | 125.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 125.0 | |
| Total | 5 | 125.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Graham Cook | Director | 79 | 20 | |
| Ruby Cato | Director | 24 | 5 | |
| Andrew Midler | Executive Officer | 27 | 2 | |
| Farida Udaipurwala | Executive Officer | 5 | 2 | |
| Savitr Capital LLC | Executive Officer | 5 | 2 | |
| Jon Borchardt | Executive Officer | 5 | 2 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001442757] | |
| 3 | [0001442757] | |
| 5 | [0001442757] | |
| SC 13G | [0001442757] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Savitr Capital LLC | Savitr Capital LLC | [2020-01-28] |
| Savitr Capital LLC | AP Pharma Inc /DE/ | [2013-02-15] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $0.2B |
| Serves | Research |
| Fund Types | Hedge Fund |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Heron Therapeutics Inc /DE/ | |
| Savitr Capital LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-12-23 | Sell | 1,000 | $9.80 | 9,800 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-12-22 | Sell | 2,000 | $9.65 | 19,300 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-12-19 | Sell | 1,000 | $9.33 | 9,330 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-12-17 | Sell | 1,000 | $9.24 | 9,240 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-12-16 | Sell | 3,700 | $9.36 | 34,632 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-10-24 | Sell | 1,000 | $7.42 | 7,420 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-09-30 | Sell | 1,000 | $8.40 | 8,400 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-09-29 | Sell | 3,000 | $8.77 | 26,310 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-09-26 | Sell | 1,000 | $8.52 | 8,520 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-09-24 | Sell | 1,000 | $8.55 | 8,550 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-09-19 | Sell | 10 | $9.10 | 91 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-07-31 | Sell | 1,000 | $9.28 | 9,280 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-07-30 | Sell | 3,000 | $9.20 | 27,600 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-07-29 | Sell | 4,000 | $9.10 | 36,400 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-07-25 | Sell | 3,000 | $9.03 | 27,090 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-07-03 | Sell | 3,300 | $12.45 | 41,085 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-06-24 | Sell | 19,147 | $12.82 | 245,465 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-03-27 | Sell | 1,000 | $14.33 | 14,330 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-03-25 | Sell | 4,000 | $14.10 | 56,400 |
|
Heron Therapeutics Inc /DE/ HRTX
Heron Therapeutics Common Stock
|
2014-03-21 | Sell | 3,000 | $15.30 | 45,900 |
| showing 20 of 26 most recent transactions | |||||